Aneroid Sphygmomanometer
FDA 510(k)EUDAMEDClass II (US FDA 510(k))
Identifiers
- 510(k) Number
- K203620 FDA 510(k)
- FDA Product Code
- DXQ FDA 510(k)
Classification
- Device Class
- Class II FDA 510(k)
- Legislation / Framework
- 21 CFR Part 870.1120 FDA 510(k)
- Regulation Number
- 870.1120 FDA 510(k)
- Advisory Committee
- Cardiovascular FDA 510(k)
- FDA Decision
- SESE Substantially Equivalent FDA 510(k)
An aneroid sphygmomanometer is a blood pressure measurement device designed to non-invasively assess arterial blood pressure in adults and children. It operates by measuring the pressure exerted by blood against the arterial walls using a mercury-free, aneroid manometer and an inflatable cuff, providing a visual reading of systolic and diastolic pressure via a dial gauge.
The device is supplied as a reusable medical instrument, intended for use in clinical, home, or office settings. It requires calibration and maintenance to ensure accuracy, with no specified sterility requirements beyond standard hygiene practices. Compliance with FDA 510(k) clearance (K203620) and MDR authorisation confirms its regulatory standing, though MRI safety and specific cuff sizes (e.g., adult, pediatric) must be verified per manufacturer instructions.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.
Authorization Coverage (2 countries)
Regulatory Authorizations
MDR
FDA_510K
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | MDR | — | Class II | Active |
| FDA 510(k) | United States | FDA_510K | K203620 | Class II | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Wuxi Exanovo Medical Instrument Co., Ltd.
Sources (2)
- FDA 510(k) K203620 24 fields · synced Oct 6, 2026
- EUDAMED 1 fields · synced May 18, 2026